Skip to content
Screener

Arcutis Biotherapeutics, Inc. ARQT Business Segments — Other Income (Expense)

Similar metrics at other companies

Sonida Senior Living logo
SNDAReportable Segment — Other Income (Expense)
$554K+201%
Archer Aviation logo
ACHRReportable Segment — Other Income (Expense)
$20.6M-51.0%
Black Rock Coffee Bar logo
BRCBReportable Segment — Other Income (Expense)
$352K+2,247%
Twist Bioscience Corporation logo
TWSTReportable Segment — Other Income (Expense)
$175K+144%
Lucid Group, Inc. logo
LCIDReportable Segment — Other Income (Expense)
-$7.87M-365%
DoorDash logo
DASHReportable Segment — Other Income (Expense)
$16M-72.9%

Other financials

Income statement

See full
Revenue$129.9M+59.3%
Gross profit$118.9M+60.7%
Operating income$16.4M+212%
Net income$15.0M+194%
EPS (diluted)$0.11+185%

Balance sheet

See full
Cash & equivalents$34.4M-52.9%
Total debt$114.1M+3.6%
Total equity$220.6M+58.7%
Total assets$488.5M+38.6%

Cash flow

See full
Operating cash flow$12.6M
CapEx$158.0K+103%
Free cash flow$12.5M

Valuation

See full
Market cap$3.32B+81.4%
Enterprise value$3.4B+82.1%
P/S7.2×+0.2×

Profitability

See full
Gross margin91.1%+2.0pp
Operating margin-12%-5.7pp
Net margin-13.9%-6.6pp
FCF margin-52.5%-21.9pp

Returns & leverage

See full
Return on equity-28.2%-13.0pp
Debt / equity0.5×-0.3×
Current ratio2.9×-0.3×

Where this comes from

Reported directly by Arcutis Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:21 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001787306-26-000051
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Other segment expenses(1)6,2955,50912,15612,694
Total operating expenses113,43296,115227,919186,490
Operating income (loss)16,429(14,611)7,340(39,140)
Interest income2,2792,0764,5544,613
Interest expense(3,406)(3,029)(7,774)(6,011)
Other income (expense), net(157)20(177)213
Provision for income taxes136342229621
Segment and consolidated net income (loss)$15,009$(15,886)$3,714$(40,946)

Item 1. Financial Statements (Unaudited)

FAQ

What is Arcutis Biotherapeutics, Inc.'s business segments — other income (expense)?
Arcutis Biotherapeutics, Inc. (ARQT) reported business segments — other income (expense) of -$157K in Q2 2026.
How has Arcutis Biotherapeutics, Inc.'s business segments — other income (expense) changed year-over-year?
Arcutis Biotherapeutics, Inc.'s business segments — other income (expense) decreased by 885.0% year-over-year, from $20K to -$157K.
What does business segments — other income (expense) mean?
Includes non-operating gains or losses that do not fit into standard categories like interest or taxes, such as foreign exchange impacts or asset disposals. This metric captures the net impact of peripheral financial events on the segment's bottom line.

Ask your AI about Arcutis Biotherapeutics, Inc.'s business segments — other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude